0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Influenza Vaccination Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-12M6165
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Influenza Vaccination Market Insights Forecast to 2028
BUY CHAPTERS

Global Influenza Vaccination Market Research Report 2024

Code: QYRE-Auto-12M6165
Report
January 2024
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Influenza Vaccination Market

Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused
The global Influenza Vaccination market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.
This report aims to provide a comprehensive presentation of the global market for Influenza Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Vaccination.

Report Scope

The Influenza Vaccination market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Influenza Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Vaccination companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Influenza Vaccination Market Report

Report Metric Details
Report Name Influenza Vaccination Market
Segment by Type
  • Egg Based
  • Cell Culture
  • Recombinant
Segment by Application
  • Hospitals
  • Research Organizations
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott (U.S.), AstraZeneca (Europe), BioCryst Pharmaceuticals (U.S.), Novartis (Europe), DAIICHI SANKYO COMPANY (Asia Pacific), GlaxoSmithKline (Europe), Hualan Biological Engineering (Asia Pacific), Mitsubishi Tanabe Pharma (Asia Pacific), F. Hoffmann-La Roche (Europe), Sanofi (Europe)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Influenza Vaccination companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Influenza Vaccination Market report?

Ans: The main players in the Influenza Vaccination Market are Abbott (U.S.), AstraZeneca (Europe), BioCryst Pharmaceuticals (U.S.), Novartis (Europe), DAIICHI SANKYO COMPANY (Asia Pacific), GlaxoSmithKline (Europe), Hualan Biological Engineering (Asia Pacific), Mitsubishi Tanabe Pharma (Asia Pacific), F. Hoffmann-La Roche (Europe), Sanofi (Europe)

What are the Application segmentation covered in the Influenza Vaccination Market report?

Ans: The Applications covered in the Influenza Vaccination Market report are Hospitals, Research Organizations

What are the Type segmentation covered in the Influenza Vaccination Market report?

Ans: The Types covered in the Influenza Vaccination Market report are Egg Based, Cell Culture, Recombinant

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Vaccination Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Egg Based
1.2.3 Cell Culture
1.2.4 Recombinant
1.3 Market by Application
1.3.1 Global Influenza Vaccination Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Research Organizations
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Influenza Vaccination Market Perspective (2019-2030)
2.2 Influenza Vaccination Growth Trends by Region
2.2.1 Global Influenza Vaccination Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Influenza Vaccination Historic Market Size by Region (2019-2024)
2.2.3 Influenza Vaccination Forecasted Market Size by Region (2025-2030)
2.3 Influenza Vaccination Market Dynamics
2.3.1 Influenza Vaccination Industry Trends
2.3.2 Influenza Vaccination Market Drivers
2.3.3 Influenza Vaccination Market Challenges
2.3.4 Influenza Vaccination Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Influenza Vaccination Players by Revenue
3.1.1 Global Top Influenza Vaccination Players by Revenue (2019-2024)
3.1.2 Global Influenza Vaccination Revenue Market Share by Players (2019-2024)
3.2 Global Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Influenza Vaccination Revenue
3.4 Global Influenza Vaccination Market Concentration Ratio
3.4.1 Global Influenza Vaccination Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Vaccination Revenue in 2023
3.5 Influenza Vaccination Key Players Head office and Area Served
3.6 Key Players Influenza Vaccination Product Solution and Service
3.7 Date of Enter into Influenza Vaccination Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Vaccination Breakdown Data by Type
4.1 Global Influenza Vaccination Historic Market Size by Type (2019-2024)
4.2 Global Influenza Vaccination Forecasted Market Size by Type (2025-2030)
5 Influenza Vaccination Breakdown Data by Application
5.1 Global Influenza Vaccination Historic Market Size by Application (2019-2024)
5.2 Global Influenza Vaccination Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Influenza Vaccination Market Size (2019-2030)
6.2 North America Influenza Vaccination Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Influenza Vaccination Market Size by Country (2019-2024)
6.4 North America Influenza Vaccination Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Influenza Vaccination Market Size (2019-2030)
7.2 Europe Influenza Vaccination Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Influenza Vaccination Market Size by Country (2019-2024)
7.4 Europe Influenza Vaccination Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Influenza Vaccination Market Size (2019-2030)
8.2 Asia-Pacific Influenza Vaccination Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Influenza Vaccination Market Size by Region (2019-2024)
8.4 Asia-Pacific Influenza Vaccination Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Influenza Vaccination Market Size (2019-2030)
9.2 Latin America Influenza Vaccination Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Influenza Vaccination Market Size by Country (2019-2024)
9.4 Latin America Influenza Vaccination Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Influenza Vaccination Market Size (2019-2030)
10.2 Middle East & Africa Influenza Vaccination Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Influenza Vaccination Market Size by Country (2019-2024)
10.4 Middle East & Africa Influenza Vaccination Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott (U.S.)
11.1.1 Abbott (U.S.) Company Detail
11.1.2 Abbott (U.S.) Business Overview
11.1.3 Abbott (U.S.) Influenza Vaccination Introduction
11.1.4 Abbott (U.S.) Revenue in Influenza Vaccination Business (2019-2024)
11.1.5 Abbott (U.S.) Recent Development
11.2 AstraZeneca (Europe)
11.2.1 AstraZeneca (Europe) Company Detail
11.2.2 AstraZeneca (Europe) Business Overview
11.2.3 AstraZeneca (Europe) Influenza Vaccination Introduction
11.2.4 AstraZeneca (Europe) Revenue in Influenza Vaccination Business (2019-2024)
11.2.5 AstraZeneca (Europe) Recent Development
11.3 BioCryst Pharmaceuticals (U.S.)
11.3.1 BioCryst Pharmaceuticals (U.S.) Company Detail
11.3.2 BioCryst Pharmaceuticals (U.S.) Business Overview
11.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Introduction
11.3.4 BioCryst Pharmaceuticals (U.S.) Revenue in Influenza Vaccination Business (2019-2024)
11.3.5 BioCryst Pharmaceuticals (U.S.) Recent Development
11.4 Novartis (Europe)
11.4.1 Novartis (Europe) Company Detail
11.4.2 Novartis (Europe) Business Overview
11.4.3 Novartis (Europe) Influenza Vaccination Introduction
11.4.4 Novartis (Europe) Revenue in Influenza Vaccination Business (2019-2024)
11.4.5 Novartis (Europe) Recent Development
11.5 DAIICHI SANKYO COMPANY (Asia Pacific)
11.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Company Detail
11.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Business Overview
11.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Introduction
11.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Revenue in Influenza Vaccination Business (2019-2024)
11.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Recent Development
11.6 GlaxoSmithKline (Europe)
11.6.1 GlaxoSmithKline (Europe) Company Detail
11.6.2 GlaxoSmithKline (Europe) Business Overview
11.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Introduction
11.6.4 GlaxoSmithKline (Europe) Revenue in Influenza Vaccination Business (2019-2024)
11.6.5 GlaxoSmithKline (Europe) Recent Development
11.7 Hualan Biological Engineering (Asia Pacific)
11.7.1 Hualan Biological Engineering (Asia Pacific) Company Detail
11.7.2 Hualan Biological Engineering (Asia Pacific) Business Overview
11.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Introduction
11.7.4 Hualan Biological Engineering (Asia Pacific) Revenue in Influenza Vaccination Business (2019-2024)
11.7.5 Hualan Biological Engineering (Asia Pacific) Recent Development
11.8 Mitsubishi Tanabe Pharma (Asia Pacific)
11.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Company Detail
11.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Business Overview
11.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Introduction
11.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Revenue in Influenza Vaccination Business (2019-2024)
11.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Recent Development
11.9 F. Hoffmann-La Roche (Europe)
11.9.1 F. Hoffmann-La Roche (Europe) Company Detail
11.9.2 F. Hoffmann-La Roche (Europe) Business Overview
11.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Introduction
11.9.4 F. Hoffmann-La Roche (Europe) Revenue in Influenza Vaccination Business (2019-2024)
11.9.5 F. Hoffmann-La Roche (Europe) Recent Development
11.10 Sanofi (Europe)
11.10.1 Sanofi (Europe) Company Detail
11.10.2 Sanofi (Europe) Business Overview
11.10.3 Sanofi (Europe) Influenza Vaccination Introduction
11.10.4 Sanofi (Europe) Revenue in Influenza Vaccination Business (2019-2024)
11.10.5 Sanofi (Europe) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Influenza Vaccination Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Egg Based
    Table 3. Key Players of Cell Culture
    Table 4. Key Players of Recombinant
    Table 5. Global Influenza Vaccination Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Influenza Vaccination Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Influenza Vaccination Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Influenza Vaccination Market Share by Region (2019-2024)
    Table 9. Global Influenza Vaccination Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Influenza Vaccination Market Share by Region (2025-2030)
    Table 11. Influenza Vaccination Market Trends
    Table 12. Influenza Vaccination Market Drivers
    Table 13. Influenza Vaccination Market Challenges
    Table 14. Influenza Vaccination Market Restraints
    Table 15. Global Influenza Vaccination Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Influenza Vaccination Market Share by Players (2019-2024)
    Table 17. Global Top Influenza Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccination as of 2023)
    Table 18. Ranking of Global Top Influenza Vaccination Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Influenza Vaccination Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Influenza Vaccination Product Solution and Service
    Table 22. Date of Enter into Influenza Vaccination Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Influenza Vaccination Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Influenza Vaccination Revenue Market Share by Type (2019-2024)
    Table 26. Global Influenza Vaccination Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Influenza Vaccination Revenue Market Share by Type (2025-2030)
    Table 28. Global Influenza Vaccination Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Influenza Vaccination Revenue Market Share by Application (2019-2024)
    Table 30. Global Influenza Vaccination Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Influenza Vaccination Revenue Market Share by Application (2025-2030)
    Table 32. North America Influenza Vaccination Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Influenza Vaccination Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Influenza Vaccination Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Influenza Vaccination Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Influenza Vaccination Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Influenza Vaccination Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Influenza Vaccination Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Influenza Vaccination Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Influenza Vaccination Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Influenza Vaccination Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Influenza Vaccination Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Influenza Vaccination Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Influenza Vaccination Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Influenza Vaccination Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Influenza Vaccination Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Abbott (U.S.) Company Detail
    Table 48. Abbott (U.S.) Business Overview
    Table 49. Abbott (U.S.) Influenza Vaccination Product
    Table 50. Abbott (U.S.) Revenue in Influenza Vaccination Business (2019-2024) & (US$ Million)
    Table 51. Abbott (U.S.) Recent Development
    Table 52. AstraZeneca (Europe) Company Detail
    Table 53. AstraZeneca (Europe) Business Overview
    Table 54. AstraZeneca (Europe) Influenza Vaccination Product
    Table 55. AstraZeneca (Europe) Revenue in Influenza Vaccination Business (2019-2024) & (US$ Million)
    Table 56. AstraZeneca (Europe) Recent Development
    Table 57. BioCryst Pharmaceuticals (U.S.) Company Detail
    Table 58. BioCryst Pharmaceuticals (U.S.) Business Overview
    Table 59. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product
    Table 60. BioCryst Pharmaceuticals (U.S.) Revenue in Influenza Vaccination Business (2019-2024) & (US$ Million)
    Table 61. BioCryst Pharmaceuticals (U.S.) Recent Development
    Table 62. Novartis (Europe) Company Detail
    Table 63. Novartis (Europe) Business Overview
    Table 64. Novartis (Europe) Influenza Vaccination Product
    Table 65. Novartis (Europe) Revenue in Influenza Vaccination Business (2019-2024) & (US$ Million)
    Table 66. Novartis (Europe) Recent Development
    Table 67. DAIICHI SANKYO COMPANY (Asia Pacific) Company Detail
    Table 68. DAIICHI SANKYO COMPANY (Asia Pacific) Business Overview
    Table 69. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product
    Table 70. DAIICHI SANKYO COMPANY (Asia Pacific) Revenue in Influenza Vaccination Business (2019-2024) & (US$ Million)
    Table 71. DAIICHI SANKYO COMPANY (Asia Pacific) Recent Development
    Table 72. GlaxoSmithKline (Europe) Company Detail
    Table 73. GlaxoSmithKline (Europe) Business Overview
    Table 74. GlaxoSmithKline (Europe) Influenza Vaccination Product
    Table 75. GlaxoSmithKline (Europe) Revenue in Influenza Vaccination Business (2019-2024) & (US$ Million)
    Table 76. GlaxoSmithKline (Europe) Recent Development
    Table 77. Hualan Biological Engineering (Asia Pacific) Company Detail
    Table 78. Hualan Biological Engineering (Asia Pacific) Business Overview
    Table 79. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product
    Table 80. Hualan Biological Engineering (Asia Pacific) Revenue in Influenza Vaccination Business (2019-2024) & (US$ Million)
    Table 81. Hualan Biological Engineering (Asia Pacific) Recent Development
    Table 82. Mitsubishi Tanabe Pharma (Asia Pacific) Company Detail
    Table 83. Mitsubishi Tanabe Pharma (Asia Pacific) Business Overview
    Table 84. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product
    Table 85. Mitsubishi Tanabe Pharma (Asia Pacific) Revenue in Influenza Vaccination Business (2019-2024) & (US$ Million)
    Table 86. Mitsubishi Tanabe Pharma (Asia Pacific) Recent Development
    Table 87. F. Hoffmann-La Roche (Europe) Company Detail
    Table 88. F. Hoffmann-La Roche (Europe) Business Overview
    Table 89. F. Hoffmann-La Roche (Europe) Influenza Vaccination Product
    Table 90. F. Hoffmann-La Roche (Europe) Revenue in Influenza Vaccination Business (2019-2024) & (US$ Million)
    Table 91. F. Hoffmann-La Roche (Europe) Recent Development
    Table 92. Sanofi (Europe) Company Detail
    Table 93. Sanofi (Europe) Business Overview
    Table 94. Sanofi (Europe) Influenza Vaccination Product
    Table 95. Sanofi (Europe) Revenue in Influenza Vaccination Business (2019-2024) & (US$ Million)
    Table 96. Sanofi (Europe) Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Influenza Vaccination Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Influenza Vaccination Market Share by Type: 2023 VS 2030
    Figure 3. Egg Based Features
    Figure 4. Cell Culture Features
    Figure 5. Recombinant Features
    Figure 6. Global Influenza Vaccination Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Influenza Vaccination Market Share by Application: 2023 VS 2030
    Figure 8. Hospitals Case Studies
    Figure 9. Research Organizations Case Studies
    Figure 10. Influenza Vaccination Report Years Considered
    Figure 11. Global Influenza Vaccination Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Influenza Vaccination Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Influenza Vaccination Market Share by Region: 2023 VS 2030
    Figure 14. Global Influenza Vaccination Market Share by Players in 2023
    Figure 15. Global Top Influenza Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccination as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Influenza Vaccination Revenue in 2023
    Figure 17. North America Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Influenza Vaccination Market Share by Country (2019-2030)
    Figure 19. United States Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Canada Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Influenza Vaccination Market Share by Country (2019-2030)
    Figure 23. Germany Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. France Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. U.K. Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Italy Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Russia Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Nordic Countries Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Influenza Vaccination Market Share by Region (2019-2030)
    Figure 31. China Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Japan Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. South Korea Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Southeast Asia Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. India Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Australia Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Influenza Vaccination Market Share by Country (2019-2030)
    Figure 39. Mexico Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Brazil Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Influenza Vaccination Market Share by Country (2019-2030)
    Figure 43. Turkey Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Saudi Arabia Influenza Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Abbott (U.S.) Revenue Growth Rate in Influenza Vaccination Business (2019-2024)
    Figure 46. AstraZeneca (Europe) Revenue Growth Rate in Influenza Vaccination Business (2019-2024)
    Figure 47. BioCryst Pharmaceuticals (U.S.) Revenue Growth Rate in Influenza Vaccination Business (2019-2024)
    Figure 48. Novartis (Europe) Revenue Growth Rate in Influenza Vaccination Business (2019-2024)
    Figure 49. DAIICHI SANKYO COMPANY (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2019-2024)
    Figure 50. GlaxoSmithKline (Europe) Revenue Growth Rate in Influenza Vaccination Business (2019-2024)
    Figure 51. Hualan Biological Engineering (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2019-2024)
    Figure 52. Mitsubishi Tanabe Pharma (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2019-2024)
    Figure 53. F. Hoffmann-La Roche (Europe) Revenue Growth Rate in Influenza Vaccination Business (2019-2024)
    Figure 54. Sanofi (Europe) Revenue Growth Rate in Influenza Vaccination Business (2019-2024)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS